ANIK — Anika Therapeutics, Inc.

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 898437 ·
Last close
$12.85
Market Cap
$171.97M
52W High
$22.88
52W Low
$9.01
ADV30
119,981
Next earnings
2026-11-06

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 30,594,000 18,837,000 -712,000 -311,000 189,600,000 44,957,000 52,023,000
Jun 2026 32,610,000 21,244,000 2,954,000 3,309,000 183,474,000 38,412,000 46,192,000
Mar 2026 29,612,000 18,997,000 -5,488,000 -5,056,000 179,387,000 41,020,000 45,486,000
Dec 2025 30,615,000 19,179,000 646,000 292,000 190,270,000 57,481,000 46,805,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$5,977,000
Investing CF
$-4,053,000
Financing CF
$-16,340,000
CapEx
$-5,415,000
Dividends Paid
—
Buybacks
$-15,057,000
EPS Diluted TTM
$-0.27
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$59,040,000
Inventory
$28,565,000
Receivables
$29,062,000
ST Investments
—
EBIT TTM
$-5,121,000
Pretax Income TTM
$-2,913,000
Interest Exp TTM
—
Analysts
2

Yahoo Snapshot (yfinance, live)

Total Revenue
$120,654,000
EBITDA
$3,040,000
Free Cash Flow
$3,062,375
Enterprise Value
$245,530,736
Total Cash
$38,412,000
Total Debt
$25,250,000
Shares Out
13,382,966
Trailing EPS
$-0.03
Book Value
$10.33
ROE
-2.2%
ROA
-0.9%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 112,819,000 -11,051,000 -10,880,000 190,270,000 46,805,000 143,465,000 11,188,000
Dec 2024 119,907,000 -5,101,000 -56,385,000 202,740,000 48,751,000 153,989,000 5,403,000
Dec 2023 120,792,000 844,000 -82,667,000 270,632,000 58,367,000 212,265,000 -1,788,000
Dec 2022 113,827,000 3,670,000 -14,859,000 349,128,000 63,565,000 285,563,000 4,409,000

TTM Snapshot

Revenues TTM
$120,654,000
NetIncome TTM
$-3,784,000
OpCashFlow TTM
—
Assets (Latest)
$183,474,000
Forward EPS
$0.95

Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)

max pain strike: $20.00 · spot: $13.62 · call volume: 17 · put volume: 41
Expected Move to 2026-12-18: ±$2.20 (16.15%) — implied range $11.42 – $15.82 · ATM straddle on $12.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
ELMD Electromed, Inc. $189.06M $23.13 —
KRMD KORU Medical Systems, Inc. $151.38M $3.49 —
PDEX PRO DEX INC $198.18M $61.93 —
INGN Inogen Inc $147.82M $5.68 —
UTMD UTAH MEDICAL PRODUCTS INC $205.06M $72.02 —

News headlines (Yahoo Finance, 1h cache)

Anika Therapeutics Inc (ANIK) Q3 2026 Earnings Call Highlights: Revenue Growth and Margin Gains ...
2026-11-06 21:17 · Yahoo
Anika Therapeutics, Inc. Q3 2026 Earnings Call Summary
2026-11-06 17:49 · Yahoo
Anika Therapeutics (ANIK) Q3 2026 Earnings Call Transcript
2026-11-06 17:28 · Yahoo
What Anika Therapeutics (ANIK) Said on Its Q3 Earnings Call
2026-11-06 16:14 · Yahoo
Anika Therapeutics (ANIK) Beats Q3 Earnings and Revenue Estimates
2026-11-06 12:25 · Yahoo
Anika: Q3 Earnings Snapshot
2026-11-06 12:22 · Yahoo
Anika Reports Third Quarter 2026 Financial Results
2026-11-06 12:05 · Yahoo
Anika to Issue Third Quarter 2026 Financial Results on Friday, November 6, 2026
2026-10-22 20:01 · Yahoo
Is Anika Therapeutics (ANIK) Outperforming Other Medical Stocks This Year?
2026-09-25 12:40 · Yahoo
Regenxbio (RGNX) Reports Q3 Loss, Misses Revenue Estimates
2026-11-05 13:35 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.